CVS Health Corporation (CVS)
CVS Health: Undervalued, But The Road To Success Is Paved With Uncertainty
I rate CVS Health as a BUY due to its undervaluation and potential for financial growth despite current sector uncertainties. CVS's revenue is growing, but profitability is declining due to retail competition and PBMs shrinking reimbursement rates. CVS's PBM business, Caremark, holds a significant market share, positioning it better than competitors like Walgreens.
Why CVS Health (CVS) is Poised to Beat Earnings Estimates Again
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Live Update: High-Yield Dividends Stocks React to China's Tariff Retaliation
The stock market remains in freefall, today on fears of a full-blown trade war having been ignited, sending the stock market officially into correction turf.
CVS Health (CVS) Rises Yet Lags Behind Market: Some Facts Worth Knowing
In the most recent trading session, CVS Health (CVS) closed at $68.07, indicating a +0.13% shift from the previous trading day.
CVS Health and Deckers Are the S&P 500's Best and Worst for the Quarter. Here's Why.
CVS Health gained 50% over the three-month period while Deckers fell nearly as much.
The 3 Best Performing S&P 500 Stocks of 2025 Q1
We're nearing the end of the calendar-year Q1, with many S&P 500 stocks delivering strong performances year-to-date despite recent volatility stemming from tariff talks and other economic developments.
CVS Health: I Don't Understand The Fuss, But The Worst Is Behind
CVS Health experienced a significant turnaround in 2025, with shares up nearly 50% after a 44% decline in 2024. The recent rally is not driven by great results or strong guidance under new CEO leadership, but rather bad ones that just weren't as terrible as expected. CVS's 2025 outlook includes modest revenue growth, improved operating income, and a focus on stabilizing margins and profitability.
4 Healthcare Stocks With Massive Gains—and More to Come
The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks are doing exceptionally well, outperforming the general market as the most successful sector of 2025 so far.
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why the Market Dipped But CVS Health (CVS) Gained Today
CVS Health (CVS) closed at $67.20 in the latest trading session, marking a +1.08% move from the prior day.
Market Pullback After a Historic Rally: What Investors Should Do Now
Instead of blindly buying during a selloff, Jeremy Mullin offers a four-step plan for 2025 to help investors pinpoint stocks and industries that will lead the next leg higher. Learn how to develop a disciplined strategy to capitalize on the market's abundant opportunities.
CVS Health (CVS) Ascends But Remains Behind Market: Some Facts to Note
In the closing of the recent trading day, CVS Health (CVS) stood at $67.91, denoting a +0.5% change from the preceding trading day.
